Puma biotechnology reports inducement awards under nasdaq listing rule 5635(c)(4)

Los angeles--(business wire)--puma biotechnology, inc. (nasdaq: pbyi), a biopharmaceutical company, announced that on june 6, 2024, the compensation committee of puma's board of directors approved the grant of an inducement restricted stock unit award covering 3,500 shares of puma common stock to one new non-executive employee. the award was granted under puma's 2017 employment inducement incentive award plan, which was adopted on april 27, 2017 and provides for the granting of equity awards to.
NDAQ Ratings Summary
NDAQ Quant Ranking